aluates Reports

$ 0.0

Automative

Global Herceptin Biosimilar Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-36V7290

Global Herceptin Biosimilar Market Insights Forecast to 2028

BUY CHAPTERS

Global Herceptin Biosimilar Market Insights, Forecast to 2030

Code: QYRE-Auto-36V7290

Report

December 2024

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Amgen Inc

AryoGen Biopharma

Biocon Ltd.

Celltrion

Gedeon Richter

Genor Biopharma

Mabion

Mylan NV

Roche

The Instituto Vital Brazil

Herceptin Biosimilar Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Herceptin Biosimilar Market

Herceptin is the cancer medication used in the treatment of the breast cancer. It is monoclonal antibodies and are used along with the chemotherapy drugs. It is also termed as a targeted therapy drug. Trastuzumab is the one of the brand name herceptin which is administered by slow injection to a vein.

The global Herceptin Biosimilar market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Herceptin Biosimilar, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Herceptin Biosimilar, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Herceptin Biosimilar, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Herceptin Biosimilar sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Herceptin Biosimilar market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Herceptin Biosimilar sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Herceptin Biosimilar Market Report

Report Metric	Details
Report Name	Herceptin Biosimilar Market
CAGR	5%
Segment by Type	Breast Cancer Colorectal Cancer Leukemia Lymphoma Other
Segment by Application	Hospital & Clinics Oncology Centers Other
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biocon, Celltrion, Gedeon Richter, Genor Biopharma, Mabion, Mylan, Roche, The Instituto Vital Brazil
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Herceptin Biosimilar in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Herceptin Biosimilar manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Herceptin Biosimilar sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Herceptin Biosimilar Market report?

Ans: The main players in the Herceptin Biosimilar Market are Biocon, Celltrion, Gedeon Richter, Genor Biopharma, Mabion, Mylan, Roche, The Instituto Vital Brazil

What are the Application segmentation covered in the Herceptin Biosimilar Market report?

Ans: The Applications covered in the Herceptin Biosimilar Market report are Hospital & Clinics, Oncology Centers, Other

What are the Type segmentation covered in the Herceptin Biosimilar Market report?

Ans: The Types covered in the Herceptin Biosimilar Market report are Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Other

Recommended Reports

Cancer Therapeutics

Pharma Biotherapeutics

Diagnostics & Biosimilars

1 Study Coverage

1.1 Herceptin Biosimilar Product Introduction

1.2 Market by Type

1.2.1 Global Herceptin Biosimilar Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Breast Cancer

1.2.3 Colorectal Cancer

1.2.4 Leukemia

1.2.5 Lymphoma

1.2.6 Other

1.3 Market by Application

1.3.1 Global Herceptin Biosimilar Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Hospital & Clinics

1.3.3 Oncology Centers

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Herceptin Biosimilar Sales Estimates and Forecasts 2019-2030

2.2 Global Herceptin Biosimilar Revenue by Region

2.2.1 Global Herceptin Biosimilar Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Herceptin Biosimilar Revenue by Region (2019-2024)

2.2.3 Global Herceptin Biosimilar Revenue by Region (2025-2030)

2.2.4 Global Herceptin Biosimilar Revenue Market Share by Region (2019-2030)

2.3 Global Herceptin Biosimilar Sales Estimates and Forecasts 2019-2030

2.4 Global Herceptin Biosimilar Sales by Region

2.4.1 Global Herceptin Biosimilar Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Herceptin Biosimilar Sales by Region (2019-2024)

2.4.3 Global Herceptin Biosimilar Sales by Region (2025-2030)

2.4.4 Global Herceptin Biosimilar Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Herceptin Biosimilar Sales by Manufacturers

3.1.1 Global Herceptin Biosimilar Sales by Manufacturers (2019-2024)

3.1.2 Global Herceptin Biosimilar Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Herceptin Biosimilar in 2023

3.2 Global Herceptin Biosimilar Revenue by Manufacturers

3.2.1 Global Herceptin Biosimilar Revenue by Manufacturers (2019-2024)

3.2.2 Global Herceptin Biosimilar Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Herceptin Biosimilar Revenue in 2023

3.3 Global Key Players of Herceptin Biosimilar, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Herceptin Biosimilar Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Herceptin Biosimilar, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Herceptin Biosimilar, Product Offered and Application

3.8 Global Key Manufacturers of Herceptin Biosimilar, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Herceptin Biosimilar Sales by Type

4.1.1 Global Herceptin Biosimilar Historical Sales by Type (2019-2024)

4.1.2 Global Herceptin Biosimilar Forecasted Sales by Type (2025-2030)

4.1.3 Global Herceptin Biosimilar Sales Market Share by Type (2019-2030)

4.2 Global Herceptin Biosimilar Revenue by Type

4.2.1 Global Herceptin Biosimilar Historical Revenue by Type (2019-2024)

4.2.2 Global Herceptin Biosimilar Forecasted Revenue by Type (2025-2030)

4.2.3 Global Herceptin Biosimilar Revenue Market Share by Type (2019-2030)

4.3 Global Herceptin Biosimilar Price by Type

4.3.1 Global Herceptin Biosimilar Price by Type (2019-2024)

4.3.2 Global Herceptin Biosimilar Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Herceptin Biosimilar Sales by Application

5.1.1 Global Herceptin Biosimilar Historical Sales by Application (2019-2024)

5.1.2 Global Herceptin Biosimilar Forecasted Sales by Application (2025-2030)

5.1.3 Global Herceptin Biosimilar Sales Market Share by Application (2019-2030)

5.2 Global Herceptin Biosimilar Revenue by Application

5.2.1 Global Herceptin Biosimilar Historical Revenue by Application (2019-2024)

5.2.2 Global Herceptin Biosimilar Forecasted Revenue by Application (2025-2030)

5.2.3 Global Herceptin Biosimilar Revenue Market Share by Application (2019-2030)

5.3 Global Herceptin Biosimilar Price by Application

5.3.1 Global Herceptin Biosimilar Price by Application (2019-2024)

5.3.2 Global Herceptin Biosimilar Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Herceptin Biosimilar Market Size by Type

6.1.1 US & Canada Herceptin Biosimilar Sales by Type (2019-2030)

6.1.2 US & Canada Herceptin Biosimilar Revenue by Type (2019-2030)

6.2 US & Canada Herceptin Biosimilar Market Size by Application

6.2.1 US & Canada Herceptin Biosimilar Sales by Application (2019-2030)

6.2.2 US & Canada Herceptin Biosimilar Revenue by Application (2019-2030)

6.3 US & Canada Herceptin Biosimilar Market Size by Country

6.3.1 US & Canada Herceptin Biosimilar Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Herceptin Biosimilar Sales by Country (2019-2030)

6.3.3 US & Canada Herceptin Biosimilar Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Herceptin Biosimilar Market Size by Type

7.1.1 Europe Herceptin Biosimilar Sales by Type (2019-2030)

7.1.2 Europe Herceptin Biosimilar Revenue by Type (2019-2030)

7.2 Europe Herceptin Biosimilar Market Size by Application

7.2.1 Europe Herceptin Biosimilar Sales by Application (2019-2030)

7.2.2 Europe Herceptin Biosimilar Revenue by Application (2019-2030)

7.3 Europe Herceptin Biosimilar Market Size by Country

7.3.1 Europe Herceptin Biosimilar Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Herceptin Biosimilar Sales by Country (2019-2030)

7.3.3 Europe Herceptin Biosimilar Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Herceptin Biosimilar Market Size

8.1.1 China Herceptin Biosimilar Sales (2019-2030)

8.1.2 China Herceptin Biosimilar Revenue (2019-2030)

8.2 China Herceptin Biosimilar Market Size by Application

8.2.1 China Herceptin Biosimilar Sales by Application (2019-2030)

8.2.2 China Herceptin Biosimilar Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Herceptin Biosimilar Market Size by Type

9.1.1 Asia Herceptin Biosimilar Sales by Type (2019-2030)

9.1.2 Asia Herceptin Biosimilar Revenue by Type (2019-2030)

9.2 Asia Herceptin Biosimilar Market Size by Application

9.2.1 Asia Herceptin Biosimilar Sales by Application (2019-2030)

9.2.2 Asia Herceptin Biosimilar Revenue by Application (2019-2030)

9.3 Asia Herceptin Biosimilar Sales by Region

9.3.1 Asia Herceptin Biosimilar Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Herceptin Biosimilar Revenue by Region (2019-2030)

9.3.3 Asia Herceptin Biosimilar Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Herceptin Biosimilar Market Size by Type

10.1.1 Middle East, Africa and Latin America Herceptin Biosimilar Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Herceptin Biosimilar Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Herceptin Biosimilar Market Size by Application

10.2.1 Middle East, Africa and Latin America Herceptin Biosimilar Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Herceptin Biosimilar Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Herceptin Biosimilar Sales by Country

10.3.1 Middle East, Africa and Latin America Herceptin Biosimilar Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Herceptin Biosimilar Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Herceptin Biosimilar Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Amgen

11.1.1 Amgen Company Information

11.1.2 Amgen Overview

11.1.3 Amgen Herceptin Biosimilar Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Amgen Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Amgen Recent Developments

11.2 AryoGen Biopharma

11.2.1 AryoGen Biopharma Company Information

11.2.2 AryoGen Biopharma Overview

11.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 AryoGen Biopharma Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 AryoGen Biopharma Recent Developments

11.3 Biocon

11.3.1 Biocon Company Information

11.3.2 Biocon Overview

11.3.3 Biocon Herceptin Biosimilar Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Biocon Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Biocon Recent Developments

11.4 Celltrion

11.4.1 Celltrion Company Information

11.4.2 Celltrion Overview

11.4.3 Celltrion Herceptin Biosimilar Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Celltrion Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Celltrion Recent Developments

11.5 Gedeon Richter

11.5.1 Gedeon Richter Company Information

11.5.2 Gedeon Richter Overview

11.5.3 Gedeon Richter Herceptin Biosimilar Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Gedeon Richter Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Gedeon Richter Recent Developments

11.6 Genor Biopharma

11.6.1 Genor Biopharma Company Information

11.6.2 Genor Biopharma Overview

11.6.3 Genor Biopharma Herceptin Biosimilar Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Genor Biopharma Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Genor Biopharma Recent Developments

11.7 Mabion

11.7.1 Mabion Company Information

11.7.2 Mabion Overview

11.7.3 Mabion Herceptin Biosimilar Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Mabion Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Mabion Recent Developments

11.8 Mylan

11.8.1 Mylan Company Information

11.8.2 Mylan Overview

11.8.3 Mylan Herceptin Biosimilar Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 Mylan Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Mylan Recent Developments

11.9 Roche

11.9.1 Roche Company Information

11.9.2 Roche Overview

11.9.3 Roche Herceptin Biosimilar Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 Roche Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Roche Recent Developments

11.10 The Instituto Vital Brazil

11.10.1 The Instituto Vital Brazil Company Information

11.10.2 The Instituto Vital Brazil Overview

11.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 The Instituto Vital Brazil Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 The Instituto Vital Brazil Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Herceptin Biosimilar Industry Chain Analysis

12.2 Herceptin Biosimilar Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Herceptin Biosimilar Production Mode & Process

12.4 Herceptin Biosimilar Sales and Marketing

12.4.1 Herceptin Biosimilar Sales Channels

12.4.2 Herceptin Biosimilar Distributors

12.5 Herceptin Biosimilar Customers

13 Market Dynamics

13.1 Herceptin Biosimilar Industry Trends

13.2 Herceptin Biosimilar Market Drivers

13.3 Herceptin Biosimilar Market Challenges

13.4 Herceptin Biosimilar Market Restraints

14 Key Findings in The Global Herceptin Biosimilar Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Amgen Inc

AryoGen Biopharma

Biocon Ltd.

Celltrion

Gedeon Richter

Genor Biopharma

Mabion

Mylan NV

Roche

The Instituto Vital Brazil

List of Tables

Table 1. Global Herceptin Biosimilar Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Breast Cancer

Table 3. Major Manufacturers of Colorectal Cancer

Table 4. Major Manufacturers of Leukemia

Table 5. Major Manufacturers of Lymphoma

Table 6. Major Manufacturers of Other

Table 7. Global Herceptin Biosimilar Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 8. Global Herceptin Biosimilar Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 9. Global Herceptin Biosimilar Revenue by Region (2019-2024) & (US$ Million)

Table 10. Global Herceptin Biosimilar Revenue by Region (2025-2030) & (US$ Million)

Table 11. Global Herceptin Biosimilar Revenue Market Share by Region (2019-2024)

Table 12. Global Herceptin Biosimilar Revenue Market Share by Region (2025-2030)

Table 13. Global Herceptin Biosimilar Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global Herceptin Biosimilar Sales by Region (2019-2024) & (K Units)

Table 15. Global Herceptin Biosimilar Sales by Region (2025-2030) & (K Units)

Table 16. Global Herceptin Biosimilar Sales Market Share by Region (2019-2024)

Table 17. Global Herceptin Biosimilar Sales Market Share by Region (2025-2030)

Table 18. Global Herceptin Biosimilar Sales by Manufacturers (2019-2024) & (K Units)

Table 19. Global Herceptin Biosimilar Sales Share by Manufacturers (2019-2024)

Table 20. Global Herceptin Biosimilar Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 21. Global Herceptin Biosimilar Revenue Share by Manufacturers (2019-2024)

Table 22. Global Key Players of Herceptin Biosimilar, Industry Ranking, 2022 VS 2023 VS 2024

Table 23. Herceptin Biosimilar Price by Manufacturers 2019-2024 (USD/Unit)

Table 24. Global Herceptin Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 25. Global Herceptin Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herceptin Biosimilar as of 2023)

Table 26. Global Key Manufacturers of Herceptin Biosimilar, Manufacturing Base Distribution and Headquarters

Table 27. Global Key Manufacturers of Herceptin Biosimilar, Product Offered and Application

Table 28. Global Key Manufacturers of Herceptin Biosimilar, Date of Enter into This Industry

Table 29. Mergers & Acquisitions, Expansion Plans

Table 30. Global Herceptin Biosimilar Sales by Type (2019-2024) & (K Units)

Table 31. Global Herceptin Biosimilar Sales by Type (2025-2030) & (K Units)

Table 32. Global Herceptin Biosimilar Sales Share by Type (2019-2024)

Table 33. Global Herceptin Biosimilar Sales Share by Type (2025-2030)

Table 34. Global Herceptin Biosimilar Revenue by Type (2019-2024) & (US$ Million)

Table 35. Global Herceptin Biosimilar Revenue by Type (2025-2030) & (US$ Million)

Table 36. Global Herceptin Biosimilar Revenue Share by Type (2019-2024)

Table 37. Global Herceptin Biosimilar Revenue Share by Type (2025-2030)

Table 38. Herceptin Biosimilar Price by Type (2019-2024) & (USD/Unit)

Table 39. Global Herceptin Biosimilar Price Forecast by Type (2025-2030) & (USD/Unit)

Table 40. Global Herceptin Biosimilar Sales by Application (2019-2024) & (K Units)

Table 41. Global Herceptin Biosimilar Sales by Application (2025-2030) & (K Units)

Table 42. Global Herceptin Biosimilar Sales Share by Application (2019-2024)

Table 43. Global Herceptin Biosimilar Sales Share by Application (2025-2030)

Table 44. Global Herceptin Biosimilar Revenue by Application (2019-2024) & (US$ Million)

Table 45. Global Herceptin Biosimilar Revenue by Application (2025-2030) & (US$ Million)

Table 46. Global Herceptin Biosimilar Revenue Share by Application (2019-2024)

Table 47. Global Herceptin Biosimilar Revenue Share by Application (2025-2030)

Table 48. Herceptin Biosimilar Price by Application (2019-2024) & (USD/Unit)

Table 49. Global Herceptin Biosimilar Price Forecast by Application (2025-2030) & (USD/Unit)

Table 50. US & Canada Herceptin Biosimilar Sales by Type (2019-2024) & (K Units)

Table 51. US & Canada Herceptin Biosimilar Sales by Type (2025-2030) & (K Units)

Table 52. US & Canada Herceptin Biosimilar Revenue by Type (2019-2024) & (US$ Million)

Table 53. US & Canada Herceptin Biosimilar Revenue by Type (2025-2030) & (US$ Million)

Table 54. US & Canada Herceptin Biosimilar Sales by Application (2019-2024) & (K Units)

Table 55. US & Canada Herceptin Biosimilar Sales by Application (2025-2030) & (K Units)

Table 56. US & Canada Herceptin Biosimilar Revenue by Application (2019-2024) & (US$ Million)

Table 57. US & Canada Herceptin Biosimilar Revenue by Application (2025-2030) & (US$ Million)

Table 58. US & Canada Herceptin Biosimilar Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 59. US & Canada Herceptin Biosimilar Revenue by Country (2019-2024) & (US$ Million)

Table 60. US & Canada Herceptin Biosimilar Revenue by Country (2025-2030) & (US$ Million)

Table 61. US & Canada Herceptin Biosimilar Sales by Country (2019-2024) & (K Units)

Table 62. US & Canada Herceptin Biosimilar Sales by Country (2025-2030) & (K Units)

Table 63. Europe Herceptin Biosimilar Sales by Type (2019-2024) & (K Units)

Table 64. Europe Herceptin Biosimilar Sales by Type (2025-2030) & (K Units)

Table 65. Europe Herceptin Biosimilar Revenue by Type (2019-2024) & (US$ Million)

Table 66. Europe Herceptin Biosimilar Revenue by Type (2025-2030) & (US$ Million)

Table 67. Europe Herceptin Biosimilar Sales by Application (2019-2024) & (K Units)

Table 68. Europe Herceptin Biosimilar Sales by Application (2025-2030) & (K Units)

Table 69. Europe Herceptin Biosimilar Revenue by Application (2019-2024) & (US$ Million)

Table 70. Europe Herceptin Biosimilar Revenue by Application (2025-2030) & (US$ Million)

Table 71. Europe Herceptin Biosimilar Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 72. Europe Herceptin Biosimilar Revenue by Country (2019-2024) & (US$ Million)

Table 73. Europe Herceptin Biosimilar Revenue by Country (2025-2030) & (US$ Million)

Table 74. Europe Herceptin Biosimilar Sales by Country (2019-2024) & (K Units)

Table 75. Europe Herceptin Biosimilar Sales by Country (2025-2030) & (K Units)

Table 76. China Herceptin Biosimilar Sales by Type (2019-2024) & (K Units)

Table 77. China Herceptin Biosimilar Sales by Type (2025-2030) & (K Units)

Table 78. China Herceptin Biosimilar Revenue by Type (2019-2024) & (US$ Million)

Table 79. China Herceptin Biosimilar Revenue by Type (2025-2030) & (US$ Million)

Table 80. China Herceptin Biosimilar Sales by Application (2019-2024) & (K Units)

Table 81. China Herceptin Biosimilar Sales by Application (2025-2030) & (K Units)

Table 82. China Herceptin Biosimilar Revenue by Application (2019-2024) & (US$ Million)

Table 83. China Herceptin Biosimilar Revenue by Application (2025-2030) & (US$ Million)

Table 84. Asia Herceptin Biosimilar Sales by Type (2019-2024) & (K Units)

Table 85. Asia Herceptin Biosimilar Sales by Type (2025-2030) & (K Units)

Table 86. Asia Herceptin Biosimilar Revenue by Type (2019-2024) & (US$ Million)

Table 87. Asia Herceptin Biosimilar Revenue by Type (2025-2030) & (US$ Million)

Table 88. Asia Herceptin Biosimilar Sales by Application (2019-2024) & (K Units)

Table 89. Asia Herceptin Biosimilar Sales by Application (2025-2030) & (K Units)

Table 90. Asia Herceptin Biosimilar Revenue by Application (2019-2024) & (US$ Million)

Table 91. Asia Herceptin Biosimilar Revenue by Application (2025-2030) & (US$ Million)

Table 92. Asia Herceptin Biosimilar Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 93. Asia Herceptin Biosimilar Revenue by Region (2019-2024) & (US$ Million)

Table 94. Asia Herceptin Biosimilar Revenue by Region (2025-2030) & (US$ Million)

Table 95. Asia Herceptin Biosimilar Sales by Region (2019-2024) & (K Units)

Table 96. Asia Herceptin Biosimilar Sales by Region (2025-2030) & (K Units)

Table 97. Middle East, Africa and Latin America Herceptin Biosimilar Sales by Type (2019-2024) & (K Units)

Table 98. Middle East, Africa and Latin America Herceptin Biosimilar Sales by Type (2025-2030) & (K Units)

Table 99. Middle East, Africa and Latin America Herceptin Biosimilar Revenue by Type (2019-2024) & (US$ Million)

Table 100. Middle East, Africa and Latin America Herceptin Biosimilar Revenue by Type (2025-2030) & (US$ Million)

Table 101. Middle East, Africa and Latin America Herceptin Biosimilar Sales by Application (2019-2024) & (K Units)

Table 102. Middle East, Africa and Latin America Herceptin Biosimilar Sales by Application (2025-2030) & (K Units)

Table 103. Middle East, Africa and Latin America Herceptin Biosimilar Revenue by Application (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Herceptin Biosimilar Revenue by Application (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Herceptin Biosimilar Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 106. Middle East, Africa and Latin America Herceptin Biosimilar Revenue by Country (2019-2024) & (US$ Million)

Table 107. Middle East, Africa and Latin America Herceptin Biosimilar Revenue by Country (2025-2030) & (US$ Million)

Table 108. Middle East, Africa and Latin America Herceptin Biosimilar Sales by Country (2019-2024) & (K Units)

Table 109. Middle East, Africa and Latin America Herceptin Biosimilar Sales by Country (2025-2030) & (K Units)

Table 110. Amgen Company Information

Table 111. Amgen Description and Major Businesses

Table 112. Amgen Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Amgen Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

Table 114. Amgen Recent Developments

Table 115. AryoGen Biopharma Company Information

Table 116. AryoGen Biopharma Description and Major Businesses

Table 117. AryoGen Biopharma Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. AryoGen Biopharma Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

Table 119. AryoGen Biopharma Recent Developments

Table 120. Biocon Company Information

Table 121. Biocon Description and Major Businesses

Table 122. Biocon Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Biocon Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

Table 124. Biocon Recent Developments

Table 125. Celltrion Company Information

Table 126. Celltrion Description and Major Businesses

Table 127. Celltrion Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Celltrion Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

Table 129. Celltrion Recent Developments

Table 130. Gedeon Richter Company Information

Table 131. Gedeon Richter Description and Major Businesses

Table 132. Gedeon Richter Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Gedeon Richter Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

Table 134. Gedeon Richter Recent Developments

Table 135. Genor Biopharma Company Information

Table 136. Genor Biopharma Description and Major Businesses

Table 137. Genor Biopharma Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 138. Genor Biopharma Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

Table 139. Genor Biopharma Recent Developments

Table 140. Mabion Company Information

Table 141. Mabion Description and Major Businesses

Table 142. Mabion Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 143. Mabion Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

Table 144. Mabion Recent Developments

Table 145. Mylan Company Information

Table 146. Mylan Description and Major Businesses

Table 147. Mylan Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 148. Mylan Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

Table 149. Mylan Recent Developments

Table 150. Roche Company Information

Table 151. Roche Description and Major Businesses

Table 152. Roche Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 153. Roche Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

Table 154. Roche Recent Developments

Table 155. The Instituto Vital Brazil Company Information

Table 156. The Instituto Vital Brazil Description and Major Businesses

Table 157. The Instituto Vital Brazil Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 158. The Instituto Vital Brazil Herceptin Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications

Table 159. The Instituto Vital Brazil Recent Developments

Table 160. Key Raw Materials Lists

Table 161. Raw Materials Key Suppliers Lists

Table 162. Herceptin Biosimilar Distributors List

Table 163. Herceptin Biosimilar Customers List

Table 164. Herceptin Biosimilar Market Trends

Table 165. Herceptin Biosimilar Market Drivers

Table 166. Herceptin Biosimilar Market Challenges

Table 167. Herceptin Biosimilar Market Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

List of Figures

Figure 1. Herceptin Biosimilar Product Picture

Figure 2. Global Herceptin Biosimilar Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Herceptin Biosimilar Market Share by Type in 2023 & 2030

Figure 4. Breast Cancer Product Picture

Figure 5. Colorectal Cancer Product Picture

Figure 6. Leukemia Product Picture

Figure 7. Lymphoma Product Picture

Figure 8. Other Product Picture

Figure 9. Global Herceptin Biosimilar Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 10. Global Herceptin Biosimilar Market Share by Application in 2023 & 2030

Figure 11. Hospital & Clinics

Figure 12. Oncology Centers

Figure 13. Other

Figure 14. Herceptin Biosimilar Report Years Considered

Figure 15. Global Herceptin Biosimilar Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Herceptin Biosimilar Revenue 2019-2030 (US$ Million)

Figure 17. Global Herceptin Biosimilar Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 18. Global Herceptin Biosimilar Revenue Market Share by Region (2019-2030)

Figure 19. Global Herceptin Biosimilar Sales 2019-2030 ((K Units)

Figure 20. Global Herceptin Biosimilar Sales Market Share by Region (2019-2030)

Figure 21. US & Canada Herceptin Biosimilar Sales YoY (2019-2030) & (K Units)

Figure 22. US & Canada Herceptin Biosimilar Revenue YoY (2019-2030) & (US$ Million)

Figure 23. Europe Herceptin Biosimilar Sales YoY (2019-2030) & (K Units)

Figure 24. Europe Herceptin Biosimilar Revenue YoY (2019-2030) & (US$ Million)

Figure 25. China Herceptin Biosimilar Sales YoY (2019-2030) & (K Units)

Figure 26. China Herceptin Biosimilar Revenue YoY (2019-2030) & (US$ Million)

Figure 27. Asia (excluding China) Herceptin Biosimilar Sales YoY (2019-2030) & (K Units)

Figure 28. Asia (excluding China) Herceptin Biosimilar Revenue YoY (2019-2030) & (US$ Million)

Figure 29. Middle East, Africa and Latin America Herceptin Biosimilar Sales YoY (2019-2030) & (K Units)

Figure 30. Middle East, Africa and Latin America Herceptin Biosimilar Revenue YoY (2019-2030) & (US$ Million)

Figure 31. The Herceptin Biosimilar Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. The Top 5 and 10 Largest Manufacturers of Herceptin Biosimilar in the World: Market Share by Herceptin Biosimilar Revenue in 2023

Figure 33. Global Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 34. Global Herceptin Biosimilar Sales Market Share by Type (2019-2030)

Figure 35. Global Herceptin Biosimilar Revenue Market Share by Type (2019-2030)

Figure 36. Global Herceptin Biosimilar Sales Market Share by Application (2019-2030)

Figure 37. Global Herceptin Biosimilar Revenue Market Share by Application (2019-2030)

Figure 38. US & Canada Herceptin Biosimilar Sales Market Share by Type (2019-2030)

Figure 39. US & Canada Herceptin Biosimilar Revenue Market Share by Type (2019-2030)

Figure 40. US & Canada Herceptin Biosimilar Sales Market Share by Application (2019-2030)

Figure 41. US & Canada Herceptin Biosimilar Revenue Market Share by Application (2019-2030)

Figure 42. US & Canada Herceptin Biosimilar Revenue Share by Country (2019-2030)

Figure 43. US & Canada Herceptin Biosimilar Sales Share by Country (2019-2030)

Figure 44. U.S. Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 45. Canada Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 46. Europe Herceptin Biosimilar Sales Market Share by Type (2019-2030)

Figure 47. Europe Herceptin Biosimilar Revenue Market Share by Type (2019-2030)

Figure 48. Europe Herceptin Biosimilar Sales Market Share by Application (2019-2030)

Figure 49. Europe Herceptin Biosimilar Revenue Market Share by Application (2019-2030)

Figure 50. Europe Herceptin Biosimilar Revenue Share by Country (2019-2030)

Figure 51. Europe Herceptin Biosimilar Sales Share by Country (2019-2030)

Figure 52. Germany Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 53. France Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 54. U.K. Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 55. Italy Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 56. Russia Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 57. China Herceptin Biosimilar Sales Market Share by Type (2019-2030)

Figure 58. China Herceptin Biosimilar Revenue Market Share by Type (2019-2030)

Figure 59. China Herceptin Biosimilar Sales Market Share by Application (2019-2030)

Figure 60. China Herceptin Biosimilar Revenue Market Share by Application (2019-2030)

Figure 61. Asia Herceptin Biosimilar Sales Market Share by Type (2019-2030)

Figure 62. Asia Herceptin Biosimilar Revenue Market Share by Type (2019-2030)

Figure 63. Asia Herceptin Biosimilar Sales Market Share by Application (2019-2030)

Figure 64. Asia Herceptin Biosimilar Revenue Market Share by Application (2019-2030)

Figure 65. Asia Herceptin Biosimilar Revenue Share by Region (2019-2030)

Figure 66. Asia Herceptin Biosimilar Sales Share by Region (2019-2030)

Figure 67. Japan Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 68. South Korea Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 69. China Taiwan Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 70. Southeast Asia Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 71. India Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 72. Middle East, Africa and Latin America Herceptin Biosimilar Sales Market Share by Type (2019-2030)

Figure 73. Middle East, Africa and Latin America Herceptin Biosimilar Revenue Market Share by Type (2019-2030)

Figure 74. Middle East, Africa and Latin America Herceptin Biosimilar Sales Market Share by Application (2019-2030)

Figure 75. Middle East, Africa and Latin America Herceptin Biosimilar Revenue Market Share by Application (2019-2030)

Figure 76. Middle East, Africa and Latin America Herceptin Biosimilar Revenue Share by Country (2019-2030)

Figure 77. Middle East, Africa and Latin America Herceptin Biosimilar Sales Share by Country (2019-2030)

Figure 78. Brazil Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 79. Mexico Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 80. Turkey Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 81. Israel Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 82. GCC Countries Herceptin Biosimilar Revenue (2019-2030) & (US$ Million)

Figure 83. Herceptin Biosimilar Value Chain

Figure 84. Herceptin Biosimilar Production Process

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Trastuzumab Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Herceptin Trastuzumab Market Research Report 2024

Biosimilar Drug Market

Global Cetuximab Biosimilar Market Research Report 2025

Bevacizumab Biosimilar Market

Global HER2 Antibody Market Research Report 2025

Trastuzumab Monoclonal Antibody Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HER 2 Targeted Drugs for Breast Cancer Market Research Report 2024

Recombinant Glycosylated Proteins Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

HER 2 Negative Breast Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic and Biosimilar Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for HR HER2 Advanced Breast Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Trastuzumab Market Research Report 2025

Global Targeted Drug HER2 Inhibitors for NSCLC Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions